Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids

Denise Wootten, John Simms, Cassandra Koole, Owen L. Woodman, Roger J. Summers, Arthur Christopoulos, Patrick M. Sexton

Research output: Contribution to journalArticle

Abstract

The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca2+ mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca2+) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH2 and GLP-1(7-37)] and exendin-4, but not on oxynto-modulin or full-length GLP-1 peptides [GLP-1(1-36)NH2 and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca2+ signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

Original languageEnglish
Pages (from-to)540-550
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume336
Issue number2
DOIs
Publication statusPublished - 1 Feb 2011

Fingerprint

Flavonoids
Glucagon-Like Peptide 1
Peptides
Hydroxyl Radical
Flavonols
flavone
Calcium Signaling
Glucagon-Like Peptide-1 Receptor
Catechin
Quercetin
Cricetulus
Type 2 Diabetes Mellitus
Ovary
Homeostasis

Cite this

Wootten, Denise ; Simms, John ; Koole, Cassandra ; Woodman, Owen L. ; Summers, Roger J. ; Christopoulos, Arthur ; Sexton, Patrick M. / Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. In: Journal of Pharmacology and Experimental Therapeutics. 2011 ; Vol. 336, No. 2. pp. 540-550.
@article{1ec8fe7fedc9470d9fdb680d2fa147d3,
title = "Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids",
abstract = "The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca2+ mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca2+) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH2 and GLP-1(7-37)] and exendin-4, but not on oxynto-modulin or full-length GLP-1 peptides [GLP-1(1-36)NH2 and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca2+ signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.",
author = "Denise Wootten and John Simms and Cassandra Koole and Woodman, {Owen L.} and Summers, {Roger J.} and Arthur Christopoulos and Sexton, {Patrick M.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1124/jpet.110.176362",
language = "English",
volume = "336",
pages = "540--550",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. / Wootten, Denise; Simms, John; Koole, Cassandra; Woodman, Owen L.; Summers, Roger J.; Christopoulos, Arthur; Sexton, Patrick M.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 336, No. 2, 01.02.2011, p. 540-550.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids

AU - Wootten, Denise

AU - Simms, John

AU - Koole, Cassandra

AU - Woodman, Owen L.

AU - Summers, Roger J.

AU - Christopoulos, Arthur

AU - Sexton, Patrick M.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca2+ mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca2+) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH2 and GLP-1(7-37)] and exendin-4, but not on oxynto-modulin or full-length GLP-1 peptides [GLP-1(1-36)NH2 and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca2+ signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

AB - The glucagon-like peptide 1 receptor (GLP-1R) is a promising target for the treatment of type II diabetes mellitus because of its role in metabolic homeostasis. In recent years, difficulties with peptide therapies have driven the search for small-molecule compounds to modulate the activity of this receptor. We recently identified quercetin, a naturally occurring flavonoid, as a probe-dependent, pathway-selective allosteric modulator of GLP-1R-mediated signaling. Using Chinese hamster ovary cells expressing the human GLP-1R, we have now extended this work to identify the structural requirements of flavonoids to modify GLP-1R binding and signaling (cAMP formation and intracellular Ca2+ mobilization) of each of the GLP-1R endogenous agonists, as well as the clinically used exogenous peptide mimetic exendin-4. This study identified a chemical series of hydroxyl flavonols with the ability to selectively augment calcium (Ca2+) signaling in a peptide agonist-specific manner, with effects only on truncated GLP-1 peptides [GLP-1(7-36)NH2 and GLP-1(7-37)] and exendin-4, but not on oxynto-modulin or full-length GLP-1 peptides [GLP-1(1-36)NH2 and GLP-1(1-37)]. In addition, the 3-hydroxyl group on the flavone backbone (i.e., a flavonol) was essential for this activity, however insufficient on its own, to produce the allosteric effects. In contrast to hydroxyl flavonols, catechin had no effect on peptide-mediated Ca2+ signaling but negatively modulated peptide-mediated cAMP formation in a probe-dependent manner. These data represent a detailed examination of the action of different flavonoids on peptide agonists at the GLP-1R and may aid in the development of future small molecule compounds targeted at this receptor.

UR - http://www.scopus.com/inward/record.url?scp=78751529194&partnerID=8YFLogxK

UR - http://jpet.aspetjournals.org/

U2 - 10.1124/jpet.110.176362

DO - 10.1124/jpet.110.176362

M3 - Article

C2 - 21075839

AN - SCOPUS:78751529194

VL - 336

SP - 540

EP - 550

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -